Yield10 Bioscience, Inc. (YTEN) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
Yield10 Bioscience Announces Third Quarter 2023 Financial Results
November 14, 2023 4:01 PM EST-Establishes "Camelina Seed Genetics to Biofuel" Platform-Advances Herbicide Tolerant Camelina Varieties toward Commercialization-Exercises Option to Finalize Exclusive, Global Commercial License to Advanced Omega-3 Technology-Management will host a conference call today at 4:30 pm (ET)
WOBURN, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the three and nine months ended September 30, 2023.
During the third quarter of 2023, we established our Camelina Seed Genetics to Biofuel platform as we completed the harvest of spring and... More
